Avg closing price
Price range

42 Ken Griffin Gilead Sciences Trades

Ken Griffin acquired 1.22 Million Gilead Sciences shares worth $88.9 Million. That's 0.09% of their equity portfolio (281st largest holding). The first Gilead Sciences trade was made in Q2 2013. Since then Ken Griffin bought shares 49 more times and sold shares on 50 occasions. The stake costed the investor $88.7 Million, netting the investor a gain of 0.2% so far.

Avg closing price
Price range
Increased shares by 2.4% (+9.29 Thousand shares) Q4 2023
Avg closing price $77.82
Price range $73.27 - $83.09
Increased shares by 31.1% (+93.1 Thousand shares) Q3 2023
Avg closing price $76.92
Price range $73.94 - $80.67
Sold 86.7% shares (-1.95 Million shares) Q2 2023
Avg closing price $79.75
Price range $76.01 - $86.70
Increased shares by 36.1% (+597 Thousand shares) Q1 2023
Avg closing price $82.82
Price range $77.31 - $88.08
Increased shares by 384.7% (+1.31 Million shares) Q4 2022
Avg closing price $79.19
Price range $62.32 - $89.47
Sold 89.1% shares (-2.79 Million shares) Q3 2022
Avg closing price $63.06
Price range $59.54 - $68.01
Increased shares by 27.7% (+677 Thousand shares) Q2 2022
Avg closing price $61.91
Price range $57.72 - $65.01
Increased shares by 268.7% (+1.79 Million shares) Q1 2022
Avg closing price $63.92
Price range $57.92 - $72.58
Increased shares by 67.6% (+268 Thousand shares) Q4 2021
Avg closing price $68.88
Price range $64.88 - $73.64
Sold 65.7% shares (-759 Thousand shares) Q3 2021
Avg closing price $70.25
Price range $67.69 - $73.03
Sold 81.1% shares (-4.97 Million shares) Q2 2021
Avg closing price $66.77
Price range $63.47 - $69.35
Increased shares by 115.7% (+3.29 Million shares) Q1 2021
Avg closing price $64.48
Price range $60.00 - $68.46
Increased shares by 56.3% (+1.02 Million shares) Q3 2020
Avg closing price $69.35
Price range $62.10 - $78.08
Increased shares by 223.8% (+1.26 Million shares) Q2 2020
Avg closing price $76.64
Price range $72.34 - $84.00
Sold 58.6% shares (-795 Thousand shares) Q1 2020
Avg closing price $69.10
Price range $62.63 - $80.22
Sold 32.4% shares (-649 Thousand shares) Q4 2019
Avg closing price $65.12
Price range $61.62 - $67.78
Sold 26.4% shares (-721 Thousand shares) Q3 2019
Avg closing price $65.37
Price range $62.51 - $69.00
Sold 52.1% shares (-2.96 Million shares) Q2 2019
Avg closing price $65.78
Price range $61.87 - $69.38
Increased shares by 76.0% (+2.46 Million shares) Q1 2019
Avg closing price $66.47
Price range $62.53 - $70.05
Sold 4.6% shares (-155 Thousand shares) Q4 2018
Avg closing price $69.90
Price range $60.54 - $79.00

News about Gilead Sciences, Inc. and Ken Griffin

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!